HNF1A-AS1 activated SHP-1 via phosphorylation, demonstrating that the HNF1α/HNF1A-AS1/SHP-1 axis may become a new treatment in hepatocellular carcinoma [43]. Here, HNF1A is linked to hepatocellular carcinoma.